Showing results (841-850 of 895) with videos related to
Sort By:
Pageof 90
Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.Frontiers in Stroke|January 16, 2026
Cerebral edema in intracerebral hemorrhage: pathogenesis, natural history, and potential treatments from translation to clinical trialsKailash Krishnan, Paula Bermell Campos, Thanh N Nguyen, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2026
Combinatorial immunotherapy drives exhaustion in tumor antigen-specific CD8+ T cells within the mouse renal tumor microenvironmentHolly R Stephens, Elizabeth Elkins, Jing Li, et al.JAMA|October 23, 1996
Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study GroupC D Saudek, W C Duckworth, A Giobbie-Hurder, et al.Biology of Reproduction|September 17, 2004
H1FOO is coupled to the initiation of oocytic growthMamoru Tanaka, Maki Kihara, Jon D Hennebold, et al.Health Technology Assessment (Winchester, England)|December 23, 2015
The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trialMark Thursz, Ewan Forrest, Paul Roderick, et al.Antimicrobial Agents and Chemotherapy|September 12, 2022
Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome InhibitorsShreeya Garg, Oriana Kreutzfeld, Sevil Chelebieva, et al.Human Reproduction (Oxford, England)|August 12, 2025
ESHRE's key research priorities in infertility: maximizing impact on science, people and society†Johanna Tassot, Aisling Ahlstrom, Antonio Capalbo, et al.Plos One|April 10, 2015
High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine isletsOrison O Woolcott, Joyce M Richey, Morvarid Kabir, et al.Cancer Discovery|September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancerEun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.Pageof 90